Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
27.9M
-
Number of holders
-
144
-
Total 13F shares, excl. options
-
19.4M
-
Shares change
-
+86.5K
-
Total reported value, excl. options
-
$956M
-
Value change
-
+$8.03M
-
Put/Call ratio
-
4.53
-
Number of buys
-
64
-
Number of sells
-
-70
-
Price
-
$49.32
Significant Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) as of Q1 2021
163 filings reported holding ENTA - ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share as of Q1 2021.
ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) has 144 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.4M shares
of 27.9M outstanding shares and own 69.7% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.73M shares), Farallon Capital Management, L.L.C. (2M shares), VANGUARD GROUP INC (1.9M shares), ARMISTICE CAPITAL, LLC (1.65M shares), STATE STREET CORP (1.1M shares), RENAISSANCE TECHNOLOGIES LLC (900K shares), PRICE T ROWE ASSOCIATES INC /MD/ (864K shares), Krensavage Asset Management, LLC (863K shares), NORTHERN TRUST CORP (645K shares), and DIMENSIONAL FUND ADVISORS LP (587K shares).
This table shows the top 144 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.